Colgate Palmolive (CL) Cost of Revenue (2009 - 2026)

Colgate Palmolive's Cost of Revenue history runs 18 years deep, the most recent figure standing at $2.1 billion for Q1 2026.

• On a quarterly basis, Cost of Revenue rose 9.04% year-over-year to $2.1 billion in Q1 2026; TTM through Mar 2026 was $8.3 billion, a 5.96% increase from a year earlier, with the FY2025 full-year figure at $8.1 billion, up 2.41% from the prior year.
• Cost of Revenue improved to $2.1 billion in Q1 2026 per CL's latest filing, from $2.1 billion in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.1 billion in Q1 2026 and bottomed at $1.8 billion in Q1 2022.
• The 5-year median for Cost of Revenue is $2.0 billion (2024), against an average of $2.0 billion.
• Across the five-year window, Cost of Revenue grew 13.26% in 2022 and retreated 5.03% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $2.1 billion in 2022, then declined by 2.68% to $2.0 billion in 2023, then retreated by 1.85% to $2.0 billion in 2024, then advanced by 6.16% to $2.1 billion in 2025, then advanced by 0.67% to $2.1 billion in 2026.
• Per Business Quant, the three latest CL Cost of Revenue figures stand at $2.1 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.1 billion (Q3 2025).